Trattamento

dell’ipertensione arteriosa polmonare

D. Libertucci

S.C. Pneumologia Gruppo aziendale IP

49%

29%

3%1%

2%

6%

10%

Alpha-1 COPD CF IPF IPAH Re-Tx Other*

*Other includes:

Sarcoidosis: 2.1%

Bronchiectasis: 0.4%

Congenital Heart Disease: 0.2%

LAM: 0.8%

OB (non-ReTx): 0.5%

Miscellaneous: 6.3%